Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
February 5, 2021 03:44 pm

FDA officials are off on a three-week sprint to review J&J COVID-19 vaccine data




Clinical Trial of Johnson & Johnson Covid-19 Vaccine
Johnson & Johnson released data from its vaccine clinical trial last week.



Johnson & Johnson announced yesterday that it had officially asked the Food and Drug Administration to authorize its COVID-19 vaccine, kicking off a process that will send its one-shot immunization through a gauntlet of analysts and experts.


If all goes as expected and the agency agrees that the benefits of the vaccine outweigh the risks, the United States could have a third shot available by the end of February. Experts hope that this vaccine — which only takes one dose and can be stored in the refrigerator — could accelerate the United States’ vaccination campaign.


Over the next few weeks, FDA officials will work at breakneck speeds to review the data submitted by Johnson & Johnson. Then, they’ll write up a report and submit it to...



Continue reading…




Original Link: https://www.theverge.com/2021/2/5/22267984/covid-vaccine-johnson-fda-one-dose-review

Share this article:    Share on Facebook
View Full Article

The Verge

The Verge is an ambitious multimedia effort founded in 2011

More About this Source Visit The Verge